Glucocorticoid Receptor Alpha as an Integrative Regulator of Host Defense: A Systems-Level Review and Framework for Immune Regulation and Homeostatic Correction

1. Glucocorticoid Receptor Alpha: An Integrative Regulator of Host Defense

GRα is a ligand-activated transcription factor in the nuclear receptor superfamily, expressed in nearly all nucleated cells. [22] Primarily activated by endogenous glucocorticoids, GRα integrates neuroendocrine stress signals with immune, metabolic, vascular, and reparative pathways through tissue-specific, context-dependent gene regulation that varies by cell type, local microenvironment, and the temporal phase of the host response. [19,22] Beyond regulating inflammatory gene transcription, GRα also influences mitochondrial bioenergetics, cellular metabolism, endothelial and epithelial barrier integrity, circadian regulation, oxidative stress, and inter-organ communication, thereby contributing to organism-wide adaptation to physiological stress and infection. [7,18] GRα functions in both the nucleus and mitochondria, providing a mechanism for coordinating nuclear gene expression with mitochondrial bioenergetics and cellular metabolism. [16,18,23]

These broad biological actions position GRα as a plausible integrative regulator of the adaptive processes that collectively determine effective host defense. From an evolutionary perspective, this capacity to coordinate diverse adaptive processes supports the hypothesis that GRα functions as a core survival receptor that contributes to organism-wide adaptation during physiological stress, infection, and critical illness. [8]

Rather than functioning solely as an anti-inflammatory receptor, GRα participates in the coordinated regulation of pathogen sensing, inflammatory signaling, antimicrobial competence, immunometabolic adaptation, vascular stability, and immune resolution and recovery, in accordance with the host response's temporal and tissue-specific requirements. [12,20,24] These diverse biological actions are mediated by genomic and non-genomic signaling mechanisms that vary by cell type, tissue microenvironment, and the evolving phase of the host response. [19,25] The context dependence of GRα signaling is further shaped by chromatin architecture, which determines the accessibility of specific regulatory regions and thereby influences which transcriptional programs GRα can engage across different cells and biological states.

2.1. Chromatin Remodeling Provides the Molecular Basis for Phase-Specific GRα Regulation

The remarkable ability of GRα to coordinate diverse biological functions across multiple tissues cannot be explained solely by ligand binding or receptor abundance. A key determinant of this context-dependent regulation is chromatin—the dynamic organization of DNA and associated proteins that governs access to the genome. [26] Chromatin determines which genes are accessible for transcription and which remain inactive, thereby providing a molecular basis for selective gene regulation during physiological adaptation. Thus, although every nucleated cell contains essentially the same DNA, only selected genes are available for activation at any given time.

Chromatin is not static. During physiological stress and infection, chromatin architecture is continuously remodeled, exposing some regions of DNA while restricting access to others. Importantly, most GRα binding occurs at regulatory regions that are already accessible before glucocorticoid activation, indicating that baseline chromatin accessibility is a major determinant of tissue-specific GRα binding and the resulting transcriptional responses. [27,28] Changes in chromatin accessibility determine which transcription factors—including GRα, NF-κB, and AP-1—can bind specific regulatory regions and regulate gene expression. Consequently, the biological actions of GRα are determined not only by receptor activation but also by the dynamic chromatin landscape in which the receptor operates. [24,25,29]

During physiological stress and infection, activation of pattern-recognition receptors rapidly induces NF-κB, AP-1, and other stress-responsive transcription factors, which in turn recruit chromatin-remodeling complexes to thousands of regulatory regions across the genome. This process increases chromatin accessibility, enabling coordinated binding of GRα with other transcriptional regulators. In addition to recognizing accessible chromatin, GRα recruits chromatin-remodeling complexes that further modify local chromatin accessibility, reorganize nucleosomes, and facilitate the recruitment of additional transcriptional regulators, thereby shaping context- and phase-specific transcriptional programs. [30,31,32]

Rather than functioning independently, GRα, NF-κB, and AP-1 operate within a shared chromatin environment in which cooperative and antagonistic interactions shape the magnitude, timing, and tissue specificity of gene expression [24,25,33] As chromatin accessibility changes during the host response, distinct regulatory regions become accessible to transcription-factor binding, enabling GRα to engage in different transcriptional programs as physiological conditions evolve. [24,25,29]

This chromatin-based model provides a molecular framework for understanding how GRα's actions may evolve across the Priming, Modulatory, and Restorative Phases described in this Review. During the Priming Phase, stress-induced chromatin remodeling may facilitate GRα-dependent transcriptional programs that support pathogen recognition, innate immune activation, immunometabolic adaptation, and antimicrobial defense. [7,24,25,33] During the Modulatory and Restorative Phases, evolving chromatin accessibility may enable transcriptional programs that restrain excessive inflammation, preserve endothelial and mitochondrial function, promote tissue repair, and ultimately restore physiologic homeostasis. [7,8,29]

Accordingly, dynamic chromatin remodeling provides a plausible mechanism through which the same activated GRα receptor can engage distinct transcriptional programs as the host response progresses from pathogen recognition to inflammatory modulation and ultimately tissue repair and restoration of physiological homeostasis. Thus, the diverse biological functions of GRα reflect, in part, dynamic changes in chromatin accessibility and transcription-factor interactions that may contribute to the phase-specific regulation of homeostatic correction. [7,8,9]

2. Biological Basis for GRα-Mediated Integration of Host Defense

2.1. Ubiquitous Cellular Distribution Enables System-Wide Coordination of Host Defense

GRα is expressed in virtually all nucleated cells, including innate and adaptive immune cells, endothelial and epithelial cells, fibroblasts, neurons, hepatocytes, skeletal muscle, adipose tissue, and other parenchymal organs. [22] Unlike most immune regulatory molecules, whose actions are largely confined to specific cell populations or signaling pathways, the nearly ubiquitous distribution of GRα provides a biological basis for regulating adaptive responses across multiple tissues and organ systems, thereby enabling organism-wide integration of the host response. [8]

In addition to its well-established nuclear actions, GRα also localizes to mitochondria, where it directly influences mitochondrial gene expression, bioenergetics, oxidative phosphorylation, reactive oxygen species homeostasis, and cellular adaptation to physiological stress. [16,34] This dual nuclear-mitochondrial localization provides a mechanistic basis for coupling nuclear transcriptional programs with mitochondrial energy metabolism, thereby linking immune regulation to the bioenergetic requirements of effective host defense. [18]

This broad cellular distribution and dual subcellular localization enable neuroendocrine stress signals to be translated into coordinated transcriptional, metabolic, vascular, immunologic, and reparative responses throughout the organism. [7] Consequently, GRα is well positioned to help coordinate adaptive cellular responses across diverse tissues, thereby integrating immune regulation with metabolic, vascular, mitochondrial, neuroendocrine, and other physiological processes required for effective host defense during infection and other forms of biological stress. [8,18]

The following sections examine these major functional domains individually while emphasizing their coordinated integration during homeostatic correction. Table 2 [4,7,8,10,13,14,16,17,19,20,21,35] provides an overview of these interconnected biological programs and summarizes the evidence for GRα regulation of pathogen recognition, innate and adaptive immunity, inflammatory regulation, tissue repair, and restoration of physiological homeostasis across the temporal phases of the host response.

Pathogen recognition is mediated by pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs), nucleotide-binding oligomerization domain–like receptors (NLRs), and RIG-I–like receptors (RLRs), which detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) and activate downstream signaling pathways involving nuclear factor kappa B (NF-κB), activator protein-1 (AP-1), and interferon regulatory factors (IRFs).

Within this integrated system, GRα does not directly mediate pathogen recognition but functions as a central regulator of immune coordination and response integration. GRα dynamically modulates PRR-driven signaling, cytokine production, immunometabolic adaptation, and downstream effector pathways in a tissue- and phase-specific manner, thereby coordinating immune sensing with antimicrobial effectiveness, tissue protection, and restoration of homeostasis.

Importantly, GRα signaling helps determine whether inflammatory responses remain pathogen-clearing or progress toward pathogen-permissive states. Appropriate GRα signaling may support mitochondrial function, phagolysosomal integrity, intracellular pathogen killing, and coordinated antimicrobial defense while constraining excessive NF-κB- and AP-1-driven inflammatory amplification. In contrast, impaired GRα signaling may contribute to dysregulated inflammatory responses that promote pathogen persistence, tissue injury, immune dysfunction, and impaired host defense.

Accordingly, effective immune regulation requires coordinated GRα-mediated integration of inflammatory control, antimicrobial competence, adaptive immune recalibration, and tissue repair, emphasizing that reduction of inflammatory cytokines alone does not necessarily indicate restoration of immune function or homeostatic resilience.

Abbreviations: PRR, pattern-recognition receptor; TLR, Toll-like receptor; NLR, nucleotide-binding oligomerization domain–like receptor; RLR, RIG-I–like receptor; PAMP, pathogen-associated molecular pattern; DAMP, damage-associated molecular pattern; NF-κB, nuclear factor kappa B; AP-1, activator protein-1; IRF, interferon regulatory factor; GRα, glucocorticoid receptor alpha.

2.2. GRα Modulates Early Host Defense Following Pathogen Recognition

Host defense begins when pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and the cGAS-STING pathway, recognize pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). [10,11] Activation of these evolutionarily conserved sensing systems triggers intracellular signaling cascades that induce inflammatory cytokines, type I interferons, antimicrobial mediators, and other early defense mechanisms required for rapid pathogen containment, activation of innate immune effector mechanisms, and initiation of adaptive immunity. [36]

GRα does not function as a pathogen-recognition receptor; instead, it modulates the magnitude, duration, and biological consequences of PRR signaling by selectively regulating downstream transcriptional programs. [12,37] Following activation by endogenous glucocorticoids released through the hypothalamic-pituitary-adrenal (HPA) axis during physiological stress and infection, GRα interacts with multiple intracellular signaling pathways to shape the quality and coordination of the early host response while preserving the capacity for effective antimicrobial defense. [7,13] As discussed above, these interactions are influenced by the evolving chromatin landscape, which shapes the accessibility of inflammatory and adaptive regulatory elements and contributes to differential transcriptional responses.

Mechanistically, GRα modulates PRR signaling through multiple complementary pathways. These include transrepression of NF-κB- and AP-1-dependent inflammatory gene expression, [37] induction of endogenous inhibitory mediators such as glucocorticoid-induced leucine zipper (GILZ) and mitogen-activated protein kinase phosphatase-1 (MKP-1), [38] and dynamic interactions with transcriptional cofactors and chromatin remodeling complexes that collectively regulate inflammatory gene expression. [12,13]

Importantly, growing evidence indicates that GRα's biological effects during early host defense are highly context-dependent. [13] Although GRα generally restrains excessive inflammatory signaling, it may also maintain—or, under selected cellular and inflammatory conditions, enhance—specific innate immune functions required for effective pathogen control. [12,13] Consequently, GRα is better viewed not simply as an anti-inflammatory receptor but as an integrative regulator of early host defense that calibrates pathogen control and limits immune-mediated tissue injury according to the tissue microenvironment and the evolving host response. [3,4]

2.3. GRα Calibrates Innate Immune Effector Functions

Innate immune effector cells constitute the first cellular line of defense following pathogen recognition, rapidly containing invading microorganisms, producing inflammatory mediators, eliminating infected cells, and initiating adaptive immunity. [19] Effective host defense requires not only rapid activation of these effector mechanisms but also precise regulation of their magnitude, duration, and resolution to prevent excessive tissue injury. [39,40]

GRα regulates innate immune effector functions in a cell-, tissue-, and context-dependent manner. During the early Priming Phase of host defense, GRα may support innate immune mechanisms downstream of pathogen recognition, inflammatory signaling, and antimicrobial defense. [7] Early activation of NF-κB and AP-1 also remodels chromatin, creating accessible regulatory regions that influence subsequent GRα-dependent transcriptional responses. As the host response shifts toward modulation and recovery, GRα helps recalibrate these responses by limiting excessive inflammation, promoting disease tolerance, and facilitating inflammatory resolution. [13] Through this adaptive recalibration, GRα influences cytokine production, cellular activation, antimicrobial activity, metabolic adaptation, and inflammatory resolution, thereby helping preserve pathogen control while limiting immune-mediated tissue injury. [7,12]

Macrophages provide one of the clearest examples of GRα-mediated regulation during innate host defense. Rather than simply suppressing macrophage function, GRα regulates macrophage polarization, phagocytosis, cytokine production, and antimicrobial defense in ways that may support effective host defense while limiting excessive inflammatory tissue injury. [15,41] Recent evidence demonstrates that endogenous glucocorticoid signaling is required for appropriate macrophage activation during Helicobacter pylori infection, where loss of GR signaling results in aberrant chromatin remodeling, impaired induction of inflammatory genes, reduced T-cell recruitment, and diminished bacterial control. [14]

Natural killer (NK) cells provide a complementary example of GRα-mediated immune regulation. During viral infection, endogenous glucocorticoids induce tissue-specific PD-1 expression on splenic NK cells, limiting excessive interferon-γ production and preventing immunopathology without compromising viral clearance. [20] These findings illustrate that GRα promotes effective host defense not by simply suppressing innate immunity but by calibrating immune effector responses to preserve pathogen control while minimizing collateral tissue damage. [40]

Neutrophils provide another example of GRα-mediated regulation during innate host defense. GRα generally restrains excessive neutrophil recruitment and activation by suppressing endothelial adhesion, chemotactic signaling, NF-κB activation, and reactive oxygen species generation, thereby reducing collateral tissue injury. [42,43] However, its effects on phagocytosis, microbial killing, and neutrophil extracellular trap (NET) formation vary by pathogen, inflammatory milieu, and the timing and duration of glucocorticoid exposure, suggesting that GRα calibrates rather than uniformly suppresses neutrophil effector functions. [44,45]

Collectively, these observations support a broader role for GRα in regulating innate immune effector functions and influencing the subsequent development of adaptive immunity. [7,19] Because innate immune responses shape the quality, magnitude, and subsequent regulation of adaptive immune responses, GRα-mediated regulation of dendritic-cell function and antigen presentation may provide an important mechanistic link between innate and adaptive host defense.

2.4. GRα Regulates the Transition from Innate to Adaptive Immunity

Dendritic cells, specialized antigen-presenting cells that capture, process, and present microbial antigens to naïve T lymphocytes, occupy a pivotal position at the interface between innate and adaptive immunity by linking pathogen recognition to antigen presentation and T-cell activation. [46,47] Consequently, regulation of dendritic cell maturation and function provides an important mechanism through which GRα can influence the transition from innate to adaptive immune responses. [48]

GRα regulates dendritic-cell maturation and function throughout the evolving host response. Within the proposed framework, during the Priming Phase of host defense, dendritic cells preserve their capacity for pathogen sensing, antigen uptake, processing, migration to secondary lymphoid organs, and initiation of adaptive immune responses. [19] As the host response evolves toward modulation, GRα can recalibrate dendritic-cell function by limiting excessive maturation, reducing co-stimulatory molecule expression, modulating pro-inflammatory cytokine production, and restraining naïve T-lymphocyte activation, thereby promoting immune regulation and limiting excessive adaptive immune activation. [49,50] Rather than uniformly suppressing dendritic-cell function, GRα can modulate the magnitude, quality, and duration of adaptive immune activation according to biological context and the evolving host response. [19,48]

2.4.1. GRα Calibrates Adaptive T-Cell Responses

Adaptive T-cell responses are essential for pathogen clearance, immunologic memory, and long-term protection. [51] However, excessive or dysregulated T-cell activation can also be a major source of immune-mediated tissue injury. [19] Consequently, effective host defense requires not only robust adaptive immunity but also precise regulation of T-cell activation, differentiation, trafficking, and resolution. [19,51]

GRα regulates adaptive T-cell responses in a cell-, tissue-, and context-dependent manner. [19,51] Rather than uniformly suppressing T-cell immunity, GRα modulates T-cell activation and differentiation according to the biological context, limiting excessive inflammatory responses while supporting effective host defense. [51] Experimental studies show that loss of endogenous GR signaling results in exaggerated T-cell activation, excessive inflammatory cytokine production, and immune-mediated tissue injury, underscoring GRα's important role in maintaining adaptive immune homeostasis during infection. [40]

GRα also shapes the functional specialization and long-term memory of adaptive immunity by regulating helper T-cell differentiation, cytotoxic T-cell responses, and memory-cell development. [51] These effects depend on the T-cell activation state, local inflammatory signals, the tissue microenvironment, and circadian neuroendocrine regulation. [52,53] Consequently, GRα functions not merely as an inhibitor of adaptive immunity but as a regulator that helps balance effective antimicrobial defense with limitation of immune-mediated tissue injury. [19]

In addition to regulating effector T-cell activation and differentiation, GRα contributes to adaptive immune homeostasis by stabilizing regulatory T-cell (Treg) function and promoting immune tolerance during inflammation and recovery. [54,55] Experimental studies demonstrate that endogenous GRα signaling preserves the suppressive phenotype of Tregs during inflammation, thereby preventing excessive effector T-cell activation and limiting immune-mediated tissue injury. [54,55] Beyond its direct effects on Tregs, GRα also contributes to inflammatory resolution by regulating pro-resolving programs in macrophages, dendritic cells, and other immune cells, thereby facilitating restoration of immune homeostasis while preserving protective immunity. [7,48] Collectively, these findings further support the concept that GRα functions not as a generalized immunosuppressive receptor but as an adaptive regulator that helps calibrate immune responses to the evolving temporal and biological requirements of host defense. [7]

The regulation of cytotoxic CD8⁺ T cells further illustrates GRα's regulatory breadth in adaptive immunity. During infection, GRα modulates CD8⁺ T-cell activation, differentiation, and effector function, thereby contributing to the balance between antimicrobial immunity and limitation of immune-mediated tissue injury. [40,51] These effects vary according to activation state, inflammatory context, and glucocorticoid exposure. In addition, GRα influences the balance between terminal effector differentiation and memory-cell formation, thereby supporting the development of long-lived protective immunity under appropriate conditions. [56] Together, these observations illustrate how GRα can calibrate cytotoxic T-cell responses while contributing to durable protective immunity. [51,56]

2.4.2. GRα Regulates Humoral Immune Responses

B lymphocytes are the principal effector cells of humoral immunity, differentiating into antibody-producing plasma cells and memory B cells that confer long-term protection against recurrent infection. [57] Although GRα's effects on B-cell biology have been studied less extensively than its actions on innate immune cells and T cells, accumulating evidence indicates that GRα regulates B-cell activation, survival, trafficking, differentiation, antibody production, and memory-cell development in a context-dependent manner. [19,58]

Rather than functioning solely as a suppressor of antibody production, endogenous GRα signaling modulates B-cell receptor (BCR) and Toll-like receptor (TLR) signaling, regulates CXCR4-dependent trafficking, and contributes to specific antibody responses while maintaining immune homeostasis. [40,57] GRα also influences the balance between effective humoral immunity and immune regulation by modulating B-cell activation in response to the inflammatory microenvironment and the evolving host response. Collectively, these observations support a broader role for GRα in regulating humoral immunity and in linking B-cell responses to broader adaptive immune processes involved in host defense and immune homeostasis. [7,19]

3. GRα Coordinates Systemic Adaptive Responses

3.1. GRα Preserves Endothelial Function and Microvascular Homeostasis During Host Defense

The vascular endothelium, a dynamic monolayer of specialized cells lining the entire circulatory system, plays a central role in host defense by regulating vascular permeability, leukocyte trafficking, coagulation, vascular tone, and tissue perfusion. [59] During infection, coordinated endothelial responses are essential for delivering immune cells and antimicrobial mediators to sites of injury while preserving microvascular integrity and organ perfusion. [60] Conversely, endothelial dysfunction contributes to capillary leak, tissue edema, dysregulated inflammation, microvascular thrombosis, impaired oxygen delivery, and multiple-organ dysfunction, making preservation of endothelial homeostasis a critical determinant of clinical outcome. [18]

GRα is increasingly recognized as a key regulator of endothelial adaptation during infection. [7,59] Rather than functioning solely as an anti-inflammatory receptor, GRα regulates endothelial responses by modulating inflammatory signaling, barrier integrity, leukocyte-endothelial interactions, vascular permeability, and microvascular homeostasis. [7,8] Experimental studies demonstrate that endothelial-specific deletion of GR markedly increases susceptibility to endotoxemia and sepsis, providing direct evidence that endothelial GR signaling contributes to vascular stability and survival during severe inflammatory stress. [60]

At the cellular level, GRα supports endothelial barrier integrity through multiple complementary mechanisms. GRα suppresses NF-κB-dependent inflammatory activation and supports the expression and organization of adherens and tight junction proteins—including vascular endothelial (VE)-cadherin, occludin, claudin-5, and zonula occludens-1 (ZO-1). [59,61] GRα also helps preserve endothelial barrier function through mechanisms involving the endothelial glycocalyx and barrier-stabilizing pathways, including sphingosine kinase-1 (SphK1), sphingosine-1-phosphate (S1P), and angiopoietin-1 (Ang-1). [18] Collectively, these mechanisms help reduce vascular permeability, limit capillary leakage, and preserve tissue oxygenation during systemic inflammation. [18,59]

Beyond maintaining barrier integrity, GRα also regulates leukocyte trafficking by regulating endothelial activation rather than preventing immune-cell recruitment. [59] Through suppression of endothelial adhesion molecules, inflammatory cytokines, and chemokine expression, GRα limits excessive leukocyte adhesion and endothelial injury while preserving the controlled recruitment of immune cells required for effective antimicrobial defense. [60,62] In parallel, GRα contributes to maintenance of vascular tone, nitric oxide homeostasis, tissue perfusion, and microvascular blood flow, thereby linking endothelial regulation to broader systemic adaptation during host response to infection. [7,63]

Collectively, these observations support the concept that GRα functions as an integrative regulator of endothelial integrity and microvascular homeostasis. By regulating endothelial inflammatory signaling, barrier integrity, leukocyte-endothelial interactions, vascular permeability, and tissue perfusion, GRα influences multiple complementary mechanisms that contribute to vascular homeostasis as the host response evolves. [59,60] These coordinated actions help maintain effective antimicrobial defense while limiting endothelial injury, capillary leak, microvascular dysfunction, and progression to multiple-organ dysfunction. [18]

3.2. GRα Coordinates Immunometabolic Adaptation and Mitochondrial Bioenergetics During Host Defense

Effective host defense is an energetically demanding process that requires coordinated regulation of cellular metabolism to sustain immune activation, antimicrobial defense, tissue repair, and the restoration of physiological homeostasis. Successful adaptation to infection, therefore, depends not only on the activation of immune responses but also on the capacity of cells and tissues to generate, distribute, and efficiently utilize metabolic energy. Increasing evidence indicates that GRα links neuroendocrine stress responses with immunometabolic adaptation and mitochondrial bioenergetics, thereby contributing to the regulation of metabolic requirements during host defense across multiple tissues and organ systems. [7,8,29]

During acute infection, endogenous glucocorticoids acting through GRα promote the redistribution of metabolic substrates required to support the increased energetic demands of host defense. Through coordinated regulation of hepatic gluconeogenesis, lipolysis, proteolysis, and ketogenesis, GRα helps maintain glucose availability while providing alternative energy substrates for immune cells and metabolically active tissues during physiological stress. [29,64] These systemic metabolic adaptations help provide the energy substrates required to sustain immune and organ function during the evolving host response.

Beyond its well-established nuclear transcriptional actions, GRα is one of the few nuclear receptors that also localizes to mitochondria. Following glucocorticoid activation, cytoplasmic GRα translocates to mitochondria, where it can directly influence mitochondrial gene transcription and bioenergetic function. [16,23] Within mitochondria, GRα interacts with mitochondrial DNA and modulates components of the oxidative phosphorylation machinery and processes involved in ATP production, oxidative phosphorylation, reactive oxygen species homeostasis, and mitochondrial quality control. [16,18,65] The dual localization of functional GRα in both the nucleus and mitochondria provides a mechanistic basis for linking nuclear transcriptional programs with mitochondrial energy metabolism, thereby connecting immune activation to the bioenergetic requirements of effective host defense. [16,18,23]

GRα also regulates immunometabolic adaptation within immune cells. During the Priming Phase of host defense, immune cells undergo metabolic reprogramming to support rapid antimicrobial activity and inflammatory signaling. As the host response evolves toward modulation and recovery, GRα contributes to metabolic reprogramming from predominantly inflammatory glycolytic programs toward greater reliance on mitochondrial oxidative phosphorylation and tricarboxylic acid (TCA)-cycle activity, thereby limiting excessive inflammation and supporting disease tolerance, inflammatory resolution, and tissue repair. [17,66,67] In macrophages, these metabolic adaptations are essential for optimal glucocorticoid responsiveness and directly regulate inflammatory gene expression and antimicrobial defense. [17,66]

Collectively, these observations support the concept that GRα functions as an integrative regulator of immunometabolic adaptation rather than merely an anti-inflammatory transcription factor. By linking nuclear transcriptional regulation to mitochondrial bioenergetics, GRα couples endocrine stress signaling to the metabolic demands of immune activation. [16,23] By regulating systemic fuel allocation, mitochondrial bioenergetics, cellular metabolism, and immune-cell metabolic programming across multiple organs, GRα may help align energy availability with the shifting metabolic demands of host defense, disease tolerance, inflammatory resolution, tissue repair, and recovery. [7,8,18]

3.3. GRα Regulates Intestinal Barrier Integrity and Microbiome–Host Interactions During Host Defense

The intestinal barrier is a dynamic interface composed of epithelial cells, tight junctions, mucus, resident immune cells, and the gut microbiota, which collectively restrict microbial translocation while permitting nutrient absorption and regulated communication between the host and its microbial environment. [68,69] During infection and critical illness, disruption of this barrier can promote dysbiosis, increased intestinal permeability, bacterial and endotoxin translocation, systemic inflammation, and remote-organ injury. [18,69]

GRα regulates intestinal barrier integrity through its effects on epithelial inflammatory signaling, tight-junction integrity, mucosal renewal, and local immune response. [18,70] Intestinal GR signaling restrains STAT1- and TNF-dependent inflammatory injury, thereby helping preserve epithelial integrity during severe inflammation. [71] However, its effects are not uniformly barrier protective. In experimental models combining glucocorticoid exposure with ethanol-induced epithelial injury, intestinal epithelial GR was associated with tight-junction disruption, increased permeability, endotoxemia, and systemic inflammation, showing that GRα effects on barrier function vary by biological context and the nature of the associated tissue injury. [72]

GRα also participates in bidirectional communication among the intestinal epithelium, the gut microbiota, and the hypothalamic-pituitary-adrenal (HPA) axis. Glucocorticoid signaling can alter microbial composition. Conversely, microbial signals and metabolites—including short-chain fatty acids, bile-acid derivatives, and other immunometabolites—can influence neuroendocrine activity, local glucocorticoid availability, and downstream GR signaling. [18,73,74] Experimental studies further indicate that glucocorticoid-associated alterations in microbial communities can have divergent effects, including dysbiosis or modulation of inflammatory responses, depending on treatment duration, epithelial integrity, and the underlying inflammatory environment. [72,75]

Through these reciprocal interactions, GRα integrates epithelial barrier integrity, microbiome–host communication, mucosal immunity, immunometabolic adaptation, and systemic host defense. [18,70] Appropriate GRα signaling may help limit microbial translocation, systemic inflammatory amplification, and remote-organ injury while supporting epithelial repair and restoration of intestinal homeostasis. Conversely, excessive, prolonged, or biologically mismatched glucocorticoid signaling may disrupt epithelial and microbial equilibrium.

Barrier disruption may also create a self-amplifying interaction among microbial exposure, inflammation, and impaired host defense. Experimental studies demonstrate GR-dependent regulation of epithelial barrier integrity in both intestinal and respiratory tissues, whereas excessive or contextually inappropriate glucocorticoid signaling can alter microbial communities and antimicrobial defenses. [72,76,77,78] Once barrier integrity is compromised, microbial products or organisms may gain greater access to host tissues, amplifying inflammatory signaling and systemic exposure. Importantly, this interaction may be bidirectional: elevated concentrations of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, can enhance both extracellular and intracellular bacterial growth, suggesting that dysregulated inflammation may not only damage host tissues but also create conditions that favor microbial proliferation and persistence. [79,80,81] Consistent with this reciprocal host–microbe interaction, recent multi-omics analysis of patients with acute, severe lower respiratory tract infection identified distinct lower-respiratory microbial community states associated with divergent local immune responses and clinical outcomes, including pathogen-dominant states linked to heightened inflammatory signaling and poor prognosis. [82] In parallel, dysregulated inflammatory and metabolic responses may impair effective antimicrobial function and pathogen clearance. Although the complete sequence has not been demonstrated as a single GRα-dependent pathway in humans, these observations collectively support a broader role for GRα in coordinating epithelial integrity, inflammatory regulation, and host–microbe interactions across mucosal barrier surfaces, including the gastrointestinal and respiratory tracts. Thus, these diverse and sometimes divergent effects support the proposed role of GRα as an integrative regulator of mucosal barrier–microbiome interactions, rather than as a uniformly protective or suppressive influence. [18,83]

4. GRα Integrates Organ-System Communication During Homeostatic Correction

4.1. GRα Facilitates Lymphatic Function and Inflammatory Resolution During Host Defense

The lymphatic system is an essential component of host defense, serving as the principal conduit for tissue-fluid drainage, antigen transport, immune-cell trafficking, and communication between peripheral tissues and secondary lymphoid organs. Efficient lymphatic function promotes clearance of excess interstitial fluid, inflammatory mediators, microbial products, and cellular debris while facilitating dendritic-cell migration and adaptive immune activation. Impaired lymphatic function contributes to persistent tissue edema, prolonged inflammation, impaired immune surveillance, and delayed restoration of tissue homeostasis. [84,85]

Experimental evidence indicates that GR signaling directly regulates lymphatic endothelial barrier function. In inflamed airway lymphatics, dexamethasone reversed inflammation-induced remodeling of lymphatic endothelial junctions and restored button-like junctions. Dexamethasone also increased phosphorylated nuclear GR in lymphatic endothelial cells and promoted button formation in the absence of inflammation, supporting a direct receptor-mediated effect on lymphatic endothelial plasticity. [86] In primary lymphatic endothelial cells, glucocorticoid exposure altered junctional gene expression and increased barrier integrity, effects reversed by GR antagonism, supporting receptor-dependent regulation of lymphatic endothelial permeability. [18,87] Additional evidence indicates that GRα coordinates adaptive biological processes that influence lymphatic function, including endothelial inflammatory signaling, vascular barrier integrity, leukocyte–endothelial interactions, and tissue-fluid homeostasis. [60,88,89] However, GC–GR effects on lymphatic function are not uniformly protective, as glucocorticoid exposure has also been associated with reduced lymphatic endothelial proliferation and migration and impaired lymphatic vessel contractility. [87,90]

By preserving endothelial barrier integrity, suppressing excessive NF-κB-dependent inflammatory activation, limiting leukocyte-endothelial interactions, and maintaining tissue perfusion, GRα may create physiological conditions that support efficient lymphatic drainage and interstitial fluid homeostasis. [59,60]

GRα also contributes indirectly to lymphatic immune function by regulating macrophage activation, dendritic-cell maturation, antigen presentation, and leukocyte trafficking, all of which influence antigen delivery to draining lymph nodes and the initiation and resolution of adaptive immune responses. [19,40,48] During the Modulatory and Restorative Phases of the host response, these coordinated actions facilitate clearance of inflammatory mediators and cellular debris while promoting tissue repair and restoration of physiological homeostasis. [7,8]

Collectively, current evidence supports the concept that GRα contributes to lymphatic function primarily through emerging direct effects on lymphatic endothelial barrier biology and through broader, integrated regulation of vascular integrity, immune-cell trafficking, inflammatory resolution, and interstitial fluid homeostasis.

4.2. GRα Coordinates Neuroendocrine Regulation of Host Defense

Host defense is regulated not only by local immune responses but also by integrated neuroendocrine networks that coordinate systemic adaptation to infection. These networks include the hypothalamic-pituitary-adrenal (HPA) axis, autonomic nervous system, circadian regulatory pathways, and bidirectional neuroimmune communication. [19,91] Together they synchronize immune, metabolic, cardiovascular, and behavioral responses required for effective adaptation to both bacterial and viral infections. [18,19] Consistent with this systems-level interpretation, a recent independent model of sepsis proposes that HPA-axis and glucocorticoid signaling participate in centrally coordinated neuroendocrine–metabolic regulation of the immune response, emphasizing differential effects on innate and adaptive immunity rather than uniform immunosuppression. [92] GRα serves as the principal intracellular effector of glucocorticoid signaling and interacts with these broader neuroendocrine networks to generate tissue-specific transcriptional programs that coordinate these adaptive responses. [7,18]

Direct experimental evidence demonstrates that GR signaling is required for effective neuroendocrine feedback and host-defense regulation. Genetic disruption of GR impairs negative feedback within the stress axis and reduces survival during acute stress, while cell-specific GR deletion alters susceptibility to endotoxemia and viral infection by disrupting control of IFN-γ, IL-10-dependent tolerance, and PD-1-mediated restraint of immunopathology. [20,93,94] These findings indicate that effective neuroendocrine regulation depends on receptor competence rather than circulating glucocorticoid concentrations alone. Consistent with this concept, human and translational studies of critical illness demonstrate marked tissue- and cell-specific differences in GRα expression and signaling despite shared systemic glucocorticoid exposure, with suppression in circulating neutrophils but preservation or enhancement of signaling in other tissues and immune-cell populations. [95,96,97]

During bacterial and viral infections, activation of the HPA axis increases endogenous glucocorticoid production in response to inflammatory cytokines and physiological stress. [91] Following activation by endogenous glucocorticoids, GRα regulates phase-specific transcriptional programs that initially support innate immune activation and metabolic adaptation, subsequently limit excessive inflammatory injury, and ultimately promote tissue repair and restoration of physiological homeostasis. [7,18] Intact GRα signaling is equally important for negative feedback regulation of the HPA axis, [91] whereas impaired receptor abundance or function may contribute to reduced glucocorticoid responsiveness during critical illness and represents one component of the broader pathophysiology associated with critical illness-related corticosteroid insufficiency (CIRCI). [7]

GRα also interfaces neuroendocrine regulation with autonomic and circadian control of immunity. Circadian glucocorticoid secretion coordinates daily oscillations in leukocyte trafficking, cytokine production, lymphocyte maintenance, and immune responsiveness. [19,98] Autonomic neural pathways operate in parallel with and interact with HPA-axis/glucocorticoid signaling in regulating the timing and magnitude of host-defense responses. [19] Through these interacting neuroendocrine mechanisms, GRα-dependent glucocorticoid signaling helps synchronize immune activation with predictable physiological changes and environmental stressors, enhancing host defense efficiency while minimizing unnecessary inflammatory injury. [18,19]

Neuroendocrine regulation of host defense operates through continuous bidirectional communication between the immune and nervous systems. [91] Peripheral inflammatory signals activate central neuroendocrine pathways, whereas glucocorticoid feedback through GRα recalibrates immune and tissue responses as physiological conditions evolve. [91] GRα subsequently integrates these endocrine signals into coordinated, tissue-specific transcriptional programs that regulate innate and adaptive immunity, endothelial function, immunometabolic adaptation, inflammatory resolution, and tissue repair, thereby supporting effective host defense. [7,18,20,94] Conversely, chronic inflammation, hypoxia, altered receptor isoform balance, or glucocorticoid resistance can disrupt GRα signaling, impairing this adaptive neuroimmune communication and contributing to dysregulated host responses. [7,99]

Collectively, these observations support the concept that GRα serves as a major molecular interface through which glucocorticoid signals are translated into coordinated immune, metabolic, vascular, and reparative responses during host defense. [18] By operating within integrated HPA-axis, autonomic, circadian, and bidirectional neuroimmune networks, GRα helps synchronize organism-wide adaptation across the temporal phases of the host response to bacterial and viral infections, thereby promoting effective pathogen control while facilitating restoration of physiological homeostasis. [7,19]

4.3. GRα Coordinates Tissue Repair and Restoration of Organ Function During Host Defense

Successful host defense extends beyond pathogen elimination to include restoration of tissue integrity, recovery of organ function, and re-establishment of physiological homeostasis. As the initial infectious insult is brought under control, injured tissues must transition from inflammatory defense to coordinated programs of inflammatory resolution, cellular regeneration, extracellular matrix remodeling, angiogenesis, and functional recovery. Increasing evidence indicates that GRα serves as an integrative regulator of this transition by coordinating immune, stromal, metabolic, vascular, and reparative responses in a context- and phase-dependent manner. [7,8,18]

One of the principal mechanisms through which GRα contributes to tissue repair is by facilitating the transition from inflammatory effector responses toward pro-resolving immune programs. Rather than simply suppressing inflammation, GRα promotes macrophage reprogramming toward reparative phenotypes and induces endogenous pro-resolving mediators, including glucocorticoid-induced leucine zipper (GILZ) and Annexin A1, thereby facilitating inflammatory resolution and tissue repair. [7,100] Direct genetic evidence supports a critical role for macrophage GR in this transition: myeloid GR deletion following myocardial infarction disrupts macrophage reparative programming, impairs scar formation and angiogenesis, worsens ventricular remodeling and cardiac function, and increases mortality from cardiac rupture. [101] Experimental studies further demonstrate that glucocorticoid-induced macrophage reprogramming requires AMPKα1-FOXO3 signaling, linking GR-dependent transcriptional responses to metabolic programs required for regenerative inflammation. [21]

GRα effects on tissue repair are not uniformly regenerative and vary by cell type, tissue context, and injury phase. Endothelial GR loss accelerates fibrotic remodeling and disrupts metabolic and inflammatory programs, supporting a protective role for endothelial GR during tissue repair. [102] Conversely, glucocorticoid–GR signaling can restrain selected regenerative processes: glucocorticoid exposure improves epithelial barrier organization while delaying epithelial migration and wound closure, and myeloid GR deletion after spinal cord injury has been associated with improved neurological recovery. [103,104] These divergent effects emphasize that GRα regulates the balance among inflammatory resolution, structural stabilization, remodeling, and regeneration rather than functioning as a uniformly pro-reparative signal.

GRα also coordinates structural repair by regulating interactions among immune cells, fibroblasts, endothelial cells, epithelial cells, and the extracellular matrix. Direct receptor-specific studies demonstrate that GR signaling regulates multiple components of post-injury remodeling and regeneration, including scar formation, angiogenesis, fibroblast differentiation, cellular proliferation, and functional recovery. Importantly, these effects are strongly cell- and context-dependent: macrophage GR is required for effective scar formation, angiogenesis, and cardiac remodeling after myocardial infarction, whereas cardiomyocyte GR restrains proliferative regeneration, with GR deletion or antagonism enhancing cardiomyocyte cell-cycle re-entry and cardiac muscle regeneration. [101,105,106] These divergent effects indicate that GRα regulates the balance among inflammatory resolution, structural repair, and regenerative growth rather than functioning as a uniformly pro- or anti-regenerative signal.

Beyond structural repair, GRα supports restoration of organ function by coordinating tissue repair with mitochondrial recovery, vascular homeostasis, and cellular bioenergetics. Tissue-specific GRα signaling contributes to recovery of pulmonary gas exchange, cardiovascular integrity, intestinal barrier function, and other organ-specific adaptive programs required to restore physiological function following severe infection and critical illness. [18] Experimental and translational studies further indicate that preserving tissue-specific GRα signaling supports effective repair responses, whereas impaired GRα expression or function may delay recovery and contribute to persistent organ dysfunction during prolonged critical illness. [101,107]

Collectively, these observations support the concept that GRα functions as a context- and phase-dependent regulator of tissue repair rather than merely an anti-inflammatory receptor. By coordinating immune-cell reprogramming, stromal remodeling, extracellular matrix homeostasis, angiogenesis, barrier reconstruction, mitochondrial recovery, and tissue-specific regeneration, GRα orchestrates the transition from inflammatory injury to restoration of organ structure and physiological function. These integrated adaptive programs characterize the Restorative Phase of homeostatic correction and are essential for successful recovery from both bacterial and viral infections. [7,8,18]

4.4. GRα Integrates Inter-Organ Communication Networks During Host Defense

Host defense is increasingly recognized as a systems-level adaptive process that requires coordinated communication among immune, neuroendocrine, metabolic, vascular, lymphatic, epithelial, and stromal tissues, rather than the independent function of individual organ systems. Effective adaptation to bacterial and viral infections therefore depends on continuous bidirectional communication that synchronizes pathogen recognition, inflammatory responses, metabolic adaptation, tissue protection, and regenerative processes across the organism. GRα is well positioned to coordinate these interactions because it is expressed in virtually all nucleated cells and translates systemic glucocorticoid signals into tissue-specific transcriptional programs based on biological context, thereby contributing to organism-wide adaptive responses during host defense. [13,19,29]

Unlike most immune regulators, whose activity is largely confined to individual cell populations or signaling pathways, GRα regulates multiple interconnected biological systems through tissue-specific, context-dependent signaling across diverse cell populations and organ systems. Throughout this Review, GRα has been shown to coordinate pathogen sensing, innate and adaptive immunity, endothelial function, immunometabolic adaptation, mitochondrial bioenergetics, intestinal barrier integrity, lymphatic regulation, neuroendocrine communication, and tissue repair. These coordinated actions illustrate that host defense is best understood as an integrated network of interacting adaptive systems rather than as a collection of isolated biological responses. [13,19]

Integration across organ systems is achieved because glucocorticoid signals are interpreted differently within individual tissues shaped by local chromatin accessibility, GR isoform expression, intracellular coregulators, glucocorticoid metabolism, and the prevailing inflammatory microenvironment. [29,99,108] Emerging evidence further indicates that, in addition to regulation mediated by local chromatin accessibility, GRα also regulates gene expression through long-range three-dimensional chromatin interactions that coordinate enhancer-promoter communication across the genome, providing an additional mechanism by which tissue-specific transcriptional programs are integrated during homeostatic correction. [109,110] Consequently, a single endocrine signal can simultaneously promote innate immune activation in one tissue, preserve endothelial integrity in another, regulate mitochondrial bioenergetics elsewhere, and initiate tissue repair in damaged organs. This tissue-specific interpretation enables coordinated organism-wide adaptation while preserving the functional specialization of individual organs. [13,107]

As the host response progresses from pathogen recognition through inflammatory modulation to tissue repair, GRα orchestrates sequential communication among immune, vascular, metabolic, neuroendocrine, microbiome, and reparative pathways. Rather than functioning as a generalized anti-inflammatory receptor, GRα integrates these diverse adaptive networks into phase-specific biological programs that optimize pathogen control, limit collateral tissue injury, promote disease tolerance, and restore physiological homeostasis following bacterial and viral infections. [7,19,20]

Collectively, these observations support the concept that GRα functions as a systems-level integrator of host defense. By coordinating communication among multiple organ systems, GRα synchronizes immune defense, metabolic adaptation, vascular homeostasis, neuroendocrine regulation, barrier integrity, mitochondrial function, and tissue repair throughout the temporal phases of homeostatic correction. This systems-level perspective extends the traditional view of GRα beyond inflammatory regulation and provides a biologic framework for understanding organism-wide adaptation during infection, critical illness, and recovery. [18,20,29]

5. Unified Framework for GRα-Mediated Homeostatic Correction

5.1. GRα Coordinates Pathogen Control and Disease Tolerance During Host Defense

Successful host defense requires coordinated regulation of pathogen control, inflammatory responses, metabolic adaptation, tissue protection, and repair across the temporal phases of the host response. Growing evidence indicates that GRα orchestrates these adaptive processes in a phase-specific manner, thereby promoting effective antimicrobial defense, limiting collateral tissue injury, and supporting the restoration of physiological homeostasis. Importantly, GRα does not directly eliminate invading pathogens. Rather, it coordinates immune responses together with the complementary adaptive biological processes that collectively determine effective host defense, disease tolerance, and restoration of physiological homeostasis. Through context-dependent, tissue-specific, and phase-specific regulation of these integrated adaptive programs, GRα helps coordinate the host's capacity to control infection while limiting immune-mediated tissue injury and promoting successful homeostatic correction. [14,20]

Rather than functioning as a generalized immunosuppressive receptor, GRα calibrates immune responses to the biological context, pathogen, tissue, and temporal phase of infection. During the early stages of bacterial and viral infections, endogenous glucocorticoid signaling supports appropriate activation of innate immune defenses while mobilizing the metabolic resources required for effective antimicrobial responses. [8,12] As the host response progresses through the Modulatory and Restorative Phases, GRα increasingly restrains excessive inflammatory signaling by coordinating the regulation of NF-κB, AP-1, inflammatory cytokines, oxidative stress, and immune cell activation, thereby limiting immunopathology without necessarily compromising pathogen clearance. [19,111]

Experimental studies provide direct evidence that endogenous GRα signaling contributes to effective pathogen control with disease tolerance, thereby limiting immune-mediated tissue injury without compromising pathogen clearance. [14,20] During viral infection, glucocorticoid-dependent GRα signaling induces tissue-specific PD-1 expression on splenic natural killer cells, limiting excessive interferon-γ production and preventing immune-mediated tissue injury without impairing viral clearance. [20] Similarly, studies of bacterial infection demonstrate that endogenous GR signaling contributes to appropriate macrophage activation, chromatin remodeling, inflammatory gene regulation, and effective antimicrobial defense, whereas loss of GR signaling results in dysregulated inflammation and impaired control of bacteria. [14,112]

Beyond regulating immune-cell function, GRα promotes disease tolerance by preserving the biological infrastructure required for recovery. Throughout this Review, GRα has been shown to maintain endothelial integrity, support mitochondrial bioenergetics, preserve intestinal barrier function, regulate immunometabolic adaptation, and coordinate tissue repair. These integrated actions reduce collateral tissue injury, preserve organ function, and facilitate the restoration of physiological homeostasis despite ongoing infection. [7,8,18]

The balance between host resistance and disease tolerance is highly context- and phase-dependent. Physiological endogenous glucocorticoid signaling supports coordinated adaptive responses that balance host defense with preservation of physiological homeostasis, while appropriately timed therapeutic glucocorticoid administration may support these adaptive processes in selected clinical contexts. In contrast, prolonged, excessive, or biologically inappropriate glucocorticoid exposure may impair host defense and increase susceptibility to secondary infection. Likewise, impaired GRα expression or function, altered receptor isoform balance, chronic inflammation, oxidative stress, and glucocorticoid resistance disrupt this adaptive equilibrium, contributing to persistent inflammation, tissue injury, and organ dysfunction. [19,99,113]

Collectively, these observations support the proposed conceptual framework in which GRα orchestrates a dynamic sequence of phase-specific adaptive responses throughout homeostatic correction. Rather than functioning simply as an anti-inflammatory receptor, GRα integrates pathogen control, disease tolerance, immunometabolic adaptation, vascular homeostasis, tissue repair, and inter-organ communication into coordinated biological programs that optimize survival and recovery from both bacterial and viral infections. [7,8,20]

5.2. Integrated Phase-Specific Framework for Homeostatic Correction

The preceding sections demonstrate that GRα coordinates multiple adaptive biological processes spanning immune sensing and antimicrobial defense, inflammatory regulation, endothelial and epithelial barrier integrity, immunometabolism, mitochondrial bioenergetics, neuroendocrine adaptation, lymphatic function, microbiome–gut homeostasis, tissue repair and regeneration, and inter-organ communication. Collectively, these observations support the proposed conceptual framework in which GRα orchestrates the coordinated, phase-specific integration of these adaptive biological programs throughout homeostatic correction. Table 3 [4,7,8,10,13,14,16,17,19,20,21,35] integrates these concepts by synthesizing the principal adaptive biological programs within the Priming, Modulatory, and Restorative Phases of homeostatic correction, providing a systems-level overview of the coordinated biological processes discussed throughout this Review.

6. Conclusions

Effective host defense requires far more than eliminating invading pathogens. Successful recovery depends on the coordinated regulation of immune responses and multiple complementary adaptive biological processes that preserve organ function, limit collateral tissue injury, promote disease tolerance, and restore physiological homeostasis. Although these processes have traditionally been studied as largely independent biological systems, growing experimental and clinical evidence indicates that they function as an integrated adaptive network, and that their coordination is essential for successful host defense.

This Review presents a systems-level conceptual framework in which GRα functions as an integrative regulator of host defense by coordinating context-dependent, tissue-specific, and phase-specific adaptive responses throughout homeostatic correction. Rather than attributing previously unrecognized biological functions to GRα, this framework integrates a broad body of established experimental and clinical evidence into a unified, biologically testable model that explains how the diverse actions of GRα collectively support effective host defense. Within this framework, immune regulation is integrated with complementary adaptive biological processes—including endothelial and epithelial barrier integrity, immunometabolic adaptation, mitochondrial bioenergetics, neuroendocrine regulation, lymphatic function, microbiome–host interactions, tissue repair, and inter-organ communication—that collectively enable effective pathogen control, limit immune-mediated tissue injury, and restore physiological homeostasis.

The Priming, Modulatory, and Restorative Phases provide a biologically coherent framework for understanding how these adaptive processes evolve during the host response. Rather than representing independent biological events, these phases constitute a coordinated continuum in which immune activation, inflammatory regulation, metabolic adaptation, tissue protection, and regenerative repair are dynamically integrated according to biological context and the temporal stage of infection. Within this framework, GRα is proposed to contribute to the coordination of transitions among these adaptive programs, thereby supporting both effective antimicrobial defense and the homeostatic correction required for successful recovery.

This systems-level perspective has important implications for future mechanistic investigation and precision medicine. Rather than focusing exclusively on isolated biomarkers or individual signaling pathways, future approaches may benefit from assessing the integrated adaptive capacity of biological systems that collectively determine host defense, disease tolerance, and recovery. Such an approach may improve biological phenotyping, therapeutic monitoring, and the development of individualized interventions to restore adaptive capacity and physiological resilience across acute and chronic disease states.

The principal contribution of this Review is the integration of extensive experimental and clinical evidence into a unified, biologically testable framework for understanding how the diverse actions of GRα may coordinate effective host defense with the complementary adaptive processes required for successful homeostatic correction. If supported by future mechanistic, translational, and clinical studies, this framework may provide a foundation for understanding coordinated host defense and for guiding functional assessment and precision therapeutic strategies aimed at restoring adaptive capacity, physiological resilience, and homeostasis across acute and chronic disease.